Efficacy and Safety of a 5-Day Regimen of Azacitidine for Patients with High-Risk Myelodysplastic Syndromes

被引：0
|
作者：
Fujimaki, Katsumichi [1 ]
Miyashita, Kazuho [1 ]
Kawasaki, Rika [1 ]
Tomita, Naoto [2 ]
Ishigatsubo, Yoshiaki [2 ]
机构：
[1] Fujisawa City Hosp, Fujisawa, Kanagawa, Japan
[2] Yokohama City Univ, Grad Sch Med, Yokohama, Kanagawa 232, Japan
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Azacitidine therapy in high-risk myelodysplastic syndromes (MDS): A single centre experience
    Improta, S.
    Gagliardi, A.
    Villa, M. R.
    Della Cioppa, P.
    Esposito, M.
    Izzo, G. Nitrato
    Mastrullo, L.
    LEUKEMIA RESEARCH, 2013, 37 : S152 - S152
  • [22] HEMATOLOGIC RESPONSE TO AN ALTERNATIVE DOSING SCHEDULE OF AZACITIDINE IN HIGH-RISK MYELODYSPLASTIC SYNDROMES
    Finelli, C.
    Clissa, C.
    y Follo, M.
    Curti, A.
    Paolini, S.
    Papayannidis, C.
    Testoni, N.
    Ottaviani, E.
    Parisi, S.
    Martinelli, G.
    Cocco, L.
    Baccarani, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 560 - 560
  • [23] Comparison of 7-day azacitidine and 5-day decitabine for treating myelodysplastic syndrome
    Je-Hwan Lee
    Yunsuk Choi
    Sung-Doo Kim
    Dae-Young Kim
    Jung-Hee Lee
    Kyoo-Hyung Lee
    Sang-Min Lee
    Su-Hee Cho
    Won-Sik Lee
    Young-Don Joo
    Annals of Hematology, 2013, 92 : 889 - 897
  • [24] Comparison of 7-day azacitidine and 5-day decitabine for treating myelodysplastic syndrome
    Lee, Je-Hwan
    Choi, Yunsuk
    Kim, Sung-Doo
    Kim, Dae-Young
    Lee, Jung-Hee
    Lee, Kyoo-Hyung
    Lee, Sang-Min
    Cho, Su-Hee
    Lee, Won-Sik
    Joo, Young-Don
    ANNALS OF HEMATOLOGY, 2013, 92 (07) : 889 - 897
  • [25] EXPERIENCE WITH 5-AZACITIDINE IN PATIENTS DIAGNOSED BY MYELODYSPLASTIC SYNDROMES OF INTERMEDIATE 2/HIGH RISK
    Llorente Dunia, De Miguel
    Lopez Nuria, Golbano
    Morfa Miguel, Diaz
    Juanis Jaime, Arbeteta
    Sanz Dolores, Morales
    Ramo Alejandro, Vazquez
    Maqueda Cristina, Fernandez
    Garcia Helga, Guillen
    Perez Dolores, Subira
    Martin Sonia, Herrero
    Albiz Blanca, Pinedo
    HAEMATOLOGICA, 2016, 101 : 341 - 341
  • [26] COMPARISON BETWEEN 5-DAY VS 7-DAY AZACITIDINE REGIMEN IN OLDER PATIENT WITH MYELODYSPLASTIC SYNDROME AND CHRONIC MYELOMONOCYTIC LEUKEMIA
    Adolfo Jesus, Saez Marin
    Mahillo Beatriz, Astibia
    Stock Claudia, Nunez-Torron
    de Abia Alejandro, Luna
    Martin Ana, Jimenez
    Puente Pilar, Herrera
    Francisco Javier, Lopez Jimenez
    Kennedy Kyra, Velazquez
    HAEMATOLOGICA, 2021, 106 (10) : 251 - 251
  • [27] Effectiveness of azacitidine in unselected high-risk myelodysplastic syndromes: results from the Spanish registry
    T Bernal
    P Martínez-Camblor
    J Sánchez-García
    R de Paz
    E Luño
    B Nomdedeu
    M T Ardanaz
    C Pedro
    M L Amigo
    B Xicoy
    C del Cañizo
    M Tormo
    J Bargay
    D Valcárcel
    S Brunet
    L Benlloch
    G Sanz
    Leukemia, 2015, 29 : 1875 - 1881
  • [28] Cost-effectiveness analysis of azacitidine in the treatment of high-risk myelodysplastic syndromes in Spain
    Crespo C.
    Moreno E.
    Sierra J.
    Serip S.
    Rubio M.
    Health Economics Review, 3 (1) : 1 - 10
  • [29] Effectiveness of azacitidine in unselected high-risk myelodysplastic syndromes: results from the Spanish registry
    Bernal, T.
    Martinez-Camblor, P.
    Sanchez-Garcia, J.
    de Paz, R.
    Luno, E.
    Nomdedeu, B.
    Ardanaz, M. T.
    Pedro, C.
    Amigo, M. L.
    Xicoy, B.
    del Canizo, C.
    Tormo, M.
    Bargay, J.
    Valcarcel, D.
    Brunet, S.
    Benlloch, L.
    Sanz, G.
    LEUKEMIA, 2015, 29 (09) : 1875 - 1881
  • [30] Comparison between 5-day decitabine and 7-day azacitidine for lower-risk myelodysplastic syndromes with poor prognostic features: a retrospective multicentre cohort study
    Byung-Hyun Lee
    Ka-Won Kang
    Min Ji Jeon
    Eun Sang Yu
    Dae Sik Kim
    Hojoon Choi
    Se Ryeon Lee
    Hwa Jung Sung
    Byung Soo Kim
    Chul Won Choi
    Yong Park
    Scientific Reports, 10
12345